A researcher at Quebec's University Hospital Center (CHU) has developed a treatment for endometriosis that is currently in development.
The research by Professor Donald Poirier of the CHU de Québec-Université Laval Research Center initially focused on the treatment of breast cancer, but ultimately found application in another area. With his team, they developed a group of molecules with the potential to definitively treat endometriosis.
It is a chronic disease that affects almost 10% of women. It causes acute and disruptive pain during menstruation and sexual intercourse and can lead to infertility. ©.
According to the World Health Organization, there is currently no real cure for endometriosis and existing treatments instead aim to relieve its symptoms.
The tests carried out by Professor Poirier's team on women with endometriosis proved to be very promising. The treatment is being developed in collaboration with the CHU de Québec and the pharmaceutical company Insud Pharma.
“Seeing our research leave the lab and develop into a potential treatment is an incredible achievement, especially after 30 years of work,” said Professor Poirier. Knowing that women will ultimately have a better quality of life as a result reminds us why we do research.”